PP 8.9 – 00142 Safety and activity of BCL-2 inhibitor Venetoclax in uninfected rhesus macaques

• T. Wiche Salinas,
• J. Harper,
• K. Nguyen,
• J. Auger,
• L. Tompkins,
• A. Schauer,
• D. Kulpa,
• M.L. Cottrell,
• G. Silvestri,
• M. Paiardini

Affiliations

T. Wiche Salinas

Emory National Primate Center, Emory University, Atlanta, USA

J. Harper

Emory National Primate Center, Emory University, Atlanta, USA

K. Nguyen

Emory National Primate Center, Emory University, Atlanta, USA

J. Auger

Emory National Primate Center, Emory University, Atlanta, USA

L. Tompkins

Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina At Chapel Hill, Chapel Hill, USA

A. Schauer

Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina At Chapel Hill, Chapel Hill, USA

D. Kulpa

Emory National Primate Center, Emory University, Atlanta, USA

M.L. Cottrell

Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina At Chapel Hill, Atlanta, USA

G. Silvestri

Emory National Primate Center, Emory University, Atlanta, USA

M. Paiardini

Emory National Primate Center, Emory University, Atlanta, USA